There are a number of perspectives on Ketamine as a therapeutic agent. One is to marvel at its biological activity, being an agent that can provide rapid relief of depressive symptoms and suicidal ideation. This is essentially the somewhat static box that Spravato, the branded form of Ketamine, is locked into. Pharmaceutical guidelines require its use under a so-called risk management system that restricts its use to just two indications: treatment-resistant depression and su
Effectively providing therapy to patients with a history of trauma and PTSD depends on being guided by theoretical principals. I've recently noted a convergence of ideas that leads me to put a lot of credence in what follows. One idea comes from the emerging psychedelic movement; the idea that the mind has a natural tendency to self-heal. Other thoughts derive from the writings of Abraham Maslow, an author whose fame had led me to know of his 'hierarchy of needs,' but littl